Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Lexicon Genetics Inc., DuPont deal

The companies obtained licenses to each other’s technologies related to mutant and knockout mouse clones.

Read the full 150 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE